Concepedia

Matt Deacon

MD

2

Publications

87

Citations

2

H-Index

2006

Active since

Affiliations

Pfizer (United States)(Current)

Matt Deacon is an author at Pfizer (United States) specializing in pharmacotherapy, bioanalysis, and drug discovery.

Top concepts

Publications per year

2006–2007

2

Publications

2

Fluorescently Labeled Analogues of Dofetilide as High-Affinity Fluorescence Polarization Ligands for the Human Ether-a-go-go-Related Gene (hERG) Channel

David H. Singleton, Helen Boyd, Jill Steidl‐Nichols et al. · Journal of Medicinal Chemistry · 2007 · 44 citations · Full text

Early evaluation of compound QT prolongation effects: A predictive 384-well fluorescence polarization binding assay for measuring hERG blockade

Matt Deacon, David H. Singleton, Nikki Szalkai et al. · Journal of Pharmacological and Toxicological Methods · 2006 · 43 citations

, , +6

Rows per page

1–2 of 2